Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-004625
Filing Date
2020-04-29
Accepted
2020-04-29 16:13:24
Documents
5
Period of Report
2020-06-23
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20200623xdef14a.htm DEF 14A 1351290
2 GRAPHIC tmb-20200623xdef14ag001.jpg GRAPHIC 4228
3 GRAPHIC tmb-20200623xdef14ag002.jpg GRAPHIC 3011
4 GRAPHIC tmb-20200623xdef14ag003.gif GRAPHIC 58895
5 GRAPHIC tmb-20200623xdef14ag004.gif GRAPHIC 41949
  Complete submission text file 0001558370-20-004625.txt   1501807
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37359 | Film No.: 20830439
SIC: 2834 Pharmaceutical Preparations